Patents by Inventor Kenneth A Bradley

Kenneth A Bradley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protective molecules against anthrax toxin
    Patent number: 10730848
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment of infectious diseases and exposure to toxins.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: August 4, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Eugene Gillespie, Robert Damoiseaux, Chi-Lee Charlie Ho, Brian T. Chamberlain, Michael E. Jung, Kenneth A. Bradley
  • PROTECTIVE MOLECULES AGAINST ANTHRAX TOXIN
    Publication number: 20160016930
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment of infectious diseases and exposure to toxins.
    Type: Application
    Filed: July 16, 2015
    Publication date: January 21, 2016
    Inventors: Eugene Gillespie, Robert Damoiseaux, Chi-Lee Charlie Ho, Brian T. Chamberlain, Michael E. Jung, Kenneth A. Bradley
  • STRUCTURED SILVER-MESOPOROUS SILICA NANOPARTICLES HAVING ANTIMICROBIAL ACTIVITY
    Publication number: 20120021034
    Abstract: A submicron structure having a silica body defining a plurality of pores, said silica body further defining an outer surface between pore openings of said plurality of pores; and having at least one silver nanocrystal within said silica body are described. Antimicrobial compositions comprising the submicron structure, and methods of killing or inhibiting growth of microbes using the submicron structure are described.
    Type: Application
    Filed: December 18, 2009
    Publication date: January 26, 2012
    Applicant: The Regents of the University of California
    Inventors: Jeffrey I. Zink, Monty Liong, Bryan D. France, Kenneth A. Bradley
  • Anthrax antitoxins
    Patent number: 7749517
    Abstract: The present invention provides compositions useful in preparing and/or serving as antitoxins against Bacillus anthracis, the causative agent of anthrax. The present invention also provides polypeptides and polynucleotides relating to the capillary morphogenisis gene 2 (CMG-2), vectors containing the polynucleotides and polypeptides, and host cells containing related polynucleotide molecules, all used in association with the treatment of, or the research and development of treatments for anthrax. The present invention also relates to methods for identifying molecules that bind CMG-2 and molecules that reduce the toxicity of anthrax toxin. Finally, the present invention provides methods for treating human and non-human animals suffering from anthrax.
    Type: Grant
    Filed: January 26, 2006
    Date of Patent: July 6, 2010
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: John A. Young, Heather M. Scobie, G. Jonah A. Rainey, Kenneth A. Bradley
  • Receptor for toxin
    Patent number: 7435418
    Abstract: The present invention relates to mammalian anthrax toxin receptor polypeptides and polynucleotides encoding same as well as related polypeptides and polynucleotides, vectors containing the polynucleotides and polypeptides, host cells containing related polynucleotide molecules, and cells displaying no anthrax toxin receptor on an exterior surface of the cells—minus cell lines and animals. The present invention also relates to methods for identifying molecules that bind the anthrax toxin receptor and molecules that reduce the toxicity of anthrax toxin. Finally, the present invention provides methods for treating human and non-human animals suffering from anthrax.
    Type: Grant
    Filed: January 31, 2005
    Date of Patent: October 14, 2008
    Assignees: Wisconsin Alumni Research Foundation, President and Fellows of Harvard College
    Inventors: John A. T. Young, Kenneth A Bradley, R. John Collier, Jeremy S. Mogridge
  • Receptor for toxin
    Patent number: 7074913
    Abstract: The present invention relates to mammalian anthrax toxin receptor polypeptides and polynucleotides encoding same as well as related polypeptides and polynucleotides, vectors containing the polynucleotides and polypeptides, host cells containing related polynucleotide molecules, and cells displaying no anthrax toxin receptor on an exterior surface of the cells-minus cell lines and animals. The present invention also relates to methods for identifying molecules that bind the anthrax toxin receptor and molecules that reduce the toxicity of anthrax toxin. Finally, the present invention provides methods for treating human and non-human animals suffering from anthrax.
    Type: Grant
    Filed: October 3, 2001
    Date of Patent: July 11, 2006
    Assignees: Wisconsin Alumni Research Foundation, President and Fellows of Harvard College
    Inventors: John A. T. Young, Kenneth A Bradley, R. John Collier, Jeremy S. Mogridge
  • Multiphase reactor systems based on foams for simultaneous growth and separation of products
    Patent number: 4654305
    Abstract: A nutrient gas is introduced into a liquid nutrient formulation. The resulting nutrient media is a foam. The bubble size of the gas phase is between 0.1 to 200 microns and the foam is 40-80% voids.
    Type: Grant
    Filed: October 28, 1985
    Date of Patent: March 31, 1987
    Assignee: The Board of Governors for Higher Education State of Rhode Island and Providence Plantations
    Inventors: Stanley M. Barnett, Kenneth A. Bradley